Navigation Links
Caffeine Survey Reveals Most, Least Caffeinated Cities
Date:11/6/2007

ere's the buzz on the most and least wired cities:

Most Caffeinated Cities: Least Caffeinated Cities:

1. Chicago 1. San Francisco/Oakland

2. Tampa 2. Philadelphia

3. Miami 3. New York

4. Phoenix 4. Detroit

5. Atlanta 5. Baltimore

Other cities surveyed include Houston, Boston, St. Louis, Seattle, Los Angeles, Riverside, Calif., Washington, D.C., San Diego, Minneapolis/St. Paul and Dallas/Ft Worth.

"This survey is an eye-opening study into the daily habits of thousands of Americans, and provides keen insight into consumption of many of our favorite products," said Brad Eggleston, vice president of HealthSaver. "This groundbreaking research is an important tool to help educate about the health benefits of moderate caffeine consumption in the United States."

Seattle ranked No. 1 in coffee consumption, with 58 percent of residents surveyed saying this elixir of alertness would be the most difficult caffeine product to give up.

One-half of all respondents nationwide said they drink caffeinated coffee every day, while caffeinated cola was next with a 21 percent daily consumption rate. Sweets containing chocolate and caffeinated teas are also very popular, the survey found.

Some survey findings:

Most Coffee Consumption Least Coffee Consumption

Regular coffee & specialty coffee drinks

1. Seattle/Tacoma 1. Dallas/Ft. Worth

2. Boston 2. New York

3. Houston 3. St. Louis

4. Chicago 4. Atlanta

5. Miami 5. Philadelphia

Most Cola Consumption Least Cola Consumption

Regular Coke, regular Pespi, Mountain Dew

1. Chica
'/>"/>

SOURCE HealthSaver
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Caffeine Plus Acetaminophen Toxic for Some
2. Survey reveals disparities in skin cancer knowledge, protection among high school students
3. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
4. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
5. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
6. Youth Drug Use at a Five Year Low, New Survey Shows
7. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
8. Parental surveys boost diagnosis abilities of pediatricians
9. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
10. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
11. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 2Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 5Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7